Hepatic fat, not visceral fat, is associated with gallbladder polyps: A study of 2643 healthy subjects

Background and Aim Gallbladder polyps (GBPs) appear to be strongly associated with obesity and metabolic disease. To date, the relationship between GBPs and fatty liver has not been adequately evaluated. The aim of the present study was to investigate whether GBPs are associated with fatty liver, wh...

Full description

Saved in:
Bibliographic Details
Published inJournal of gastroenterology and hepatology Vol. 30; no. 4; pp. 767 - 774
Main Authors Lim, Seon Hee, Kim, Donghee, Kang, Jin Hwa, Song, Ji Hyun, Yang, Sun Young, Yim, Jeong Yun, Chung, Su Jin, Kim, Joo Sung, Cho, Sang-Heon
Format Journal Article
LanguageEnglish
Published Australia Blackwell Publishing Ltd 01.04.2015
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background and Aim Gallbladder polyps (GBPs) appear to be strongly associated with obesity and metabolic disease. To date, the relationship between GBPs and fatty liver has not been adequately evaluated. The aim of the present study was to investigate whether GBPs are associated with fatty liver, which is an ectopic regional fat deposit, independent of visceral adipose tissue (VAT). Methods A cross‐sectional study using 2643 health checkup subjects (961 patients with GBP and 1682 age‐ and sex‐matched healthy controls) was conducted. The subjects underwent various laboratory tests, abdominal fat computed tomography (CT), and hepatic ultrasonography. Results The mean age of the subjects was 51.4 ± 8.3 years, and 74.1% were male. GBPs were significantly associated with fatty liver. Multivariate regression analysis revealed that GBPs were significantly associated with the presence of fatty liver (odds ratio [OR] 1.23, 95% confidence interval [CI]: 1.02–1.48), and adjusting for the homeostatic metabolic assessment index had little effect on this association (OR 1.23, 95% CI: 1.02–1.48). Additionally, GBPs remained significantly associated with the presence of fatty liver after adjustments for CT‐measured VAT and subcutaneous adipose tissue (OR 1.24, 95% CI: 1.03–1.50). The degree of fatty liver showed an independent (OR 1.37 95% CI: 1.03–1.80) and dose‐dependent relationship (moderate‐severe fatty liver: OR 1.55 95% CI: 1.07–2.23, P for trend = 0.014) with large GBPs (≥ 5 mm). Conclusion Fatty liver, an ectopic regional fat deposit, was found to be closely associated with GBPs independent of known metabolic risk factors, insulin resistance, and CT‐measured VAT, confirming a relevant clinical relationship between the two diseases.
AbstractList Gallbladder polyps (GBPs) appear to be strongly associated with obesity and metabolic disease. To date, the relationship between GBPs and fatty liver has not been adequately evaluated. The aim of the present study was to investigate whether GBPs are associated with fatty liver, which is an ectopic regional fat deposit, independent of visceral adipose tissue (VAT).BACKGROUND AND AIMGallbladder polyps (GBPs) appear to be strongly associated with obesity and metabolic disease. To date, the relationship between GBPs and fatty liver has not been adequately evaluated. The aim of the present study was to investigate whether GBPs are associated with fatty liver, which is an ectopic regional fat deposit, independent of visceral adipose tissue (VAT).A cross-sectional study using 2643 health checkup subjects (961 patients with GBP and 1682 age- and sex-matched healthy controls) was conducted. The subjects underwent various laboratory tests, abdominal fat computed tomography (CT), and hepatic ultrasonography.METHODSA cross-sectional study using 2643 health checkup subjects (961 patients with GBP and 1682 age- and sex-matched healthy controls) was conducted. The subjects underwent various laboratory tests, abdominal fat computed tomography (CT), and hepatic ultrasonography.The mean age of the subjects was 51.4 ± 8.3 years, and 74.1% were male. GBPs were significantly associated with fatty liver. Multivariate regression analysis revealed that GBPs were significantly associated with the presence of fatty liver (odds ratio [OR] 1.23, 95% confidence interval [CI]: 1.02-1.48), and adjusting for the homeostatic metabolic assessment index had little effect on this association (OR 1.23, 95% CI: 1.02-1.48). Additionally, GBPs remained significantly associated with the presence of fatty liver after adjustments for CT-measured VAT and subcutaneous adipose tissue (OR 1.24, 95% CI: 1.03-1.50). The degree of fatty liver showed an independent (OR 1.37 95% CI: 1.03-1.80) and dose-dependent relationship (moderate-severe fatty liver: OR 1.55 95% CI: 1.07-2.23, P for trend = 0.014) with large GBPs (≥ 5 mm).RESULTSThe mean age of the subjects was 51.4 ± 8.3 years, and 74.1% were male. GBPs were significantly associated with fatty liver. Multivariate regression analysis revealed that GBPs were significantly associated with the presence of fatty liver (odds ratio [OR] 1.23, 95% confidence interval [CI]: 1.02-1.48), and adjusting for the homeostatic metabolic assessment index had little effect on this association (OR 1.23, 95% CI: 1.02-1.48). Additionally, GBPs remained significantly associated with the presence of fatty liver after adjustments for CT-measured VAT and subcutaneous adipose tissue (OR 1.24, 95% CI: 1.03-1.50). The degree of fatty liver showed an independent (OR 1.37 95% CI: 1.03-1.80) and dose-dependent relationship (moderate-severe fatty liver: OR 1.55 95% CI: 1.07-2.23, P for trend = 0.014) with large GBPs (≥ 5 mm).Fatty liver, an ectopic regional fat deposit, was found to be closely associated with GBPs independent of known metabolic risk factors, insulin resistance, and CT-measured VAT, confirming a relevant clinical relationship between the two diseases.CONCLUSIONFatty liver, an ectopic regional fat deposit, was found to be closely associated with GBPs independent of known metabolic risk factors, insulin resistance, and CT-measured VAT, confirming a relevant clinical relationship between the two diseases.
Gallbladder polyps (GBPs) appear to be strongly associated with obesity and metabolic disease. To date, the relationship between GBPs and fatty liver has not been adequately evaluated. The aim of the present study was to investigate whether GBPs are associated with fatty liver, which is an ectopic regional fat deposit, independent of visceral adipose tissue (VAT). A cross-sectional study using 2643 health checkup subjects (961 patients with GBP and 1682 age- and sex-matched healthy controls) was conducted. The subjects underwent various laboratory tests, abdominal fat computed tomography (CT), and hepatic ultrasonography. The mean age of the subjects was 51.4 ± 8.3 years, and 74.1% were male. GBPs were significantly associated with fatty liver. Multivariate regression analysis revealed that GBPs were significantly associated with the presence of fatty liver (odds ratio [OR] 1.23, 95% confidence interval [CI]: 1.02-1.48), and adjusting for the homeostatic metabolic assessment index had little effect on this association (OR 1.23, 95% CI: 1.02-1.48). Additionally, GBPs remained significantly associated with the presence of fatty liver after adjustments for CT-measured VAT and subcutaneous adipose tissue (OR 1.24, 95% CI: 1.03-1.50). The degree of fatty liver showed an independent (OR 1.37 95% CI: 1.03-1.80) and dose-dependent relationship (moderate-severe fatty liver: OR 1.55 95% CI: 1.07-2.23, P for trend = 0.014) with large GBPs (≥ 5 mm). Fatty liver, an ectopic regional fat deposit, was found to be closely associated with GBPs independent of known metabolic risk factors, insulin resistance, and CT-measured VAT, confirming a relevant clinical relationship between the two diseases.
Background and Aim Gallbladder polyps (GBPs) appear to be strongly associated with obesity and metabolic disease. To date, the relationship between GBPs and fatty liver has not been adequately evaluated. The aim of the present study was to investigate whether GBPs are associated with fatty liver, which is an ectopic regional fat deposit, independent of visceral adipose tissue (VAT). Methods A cross‐sectional study using 2643 health checkup subjects (961 patients with GBP and 1682 age‐ and sex‐matched healthy controls) was conducted. The subjects underwent various laboratory tests, abdominal fat computed tomography (CT), and hepatic ultrasonography. Results The mean age of the subjects was 51.4 ± 8.3 years, and 74.1% were male. GBPs were significantly associated with fatty liver. Multivariate regression analysis revealed that GBPs were significantly associated with the presence of fatty liver (odds ratio [OR] 1.23, 95% confidence interval [CI]: 1.02–1.48), and adjusting for the homeostatic metabolic assessment index had little effect on this association (OR 1.23, 95% CI: 1.02–1.48). Additionally, GBPs remained significantly associated with the presence of fatty liver after adjustments for CT‐measured VAT and subcutaneous adipose tissue (OR 1.24, 95% CI: 1.03–1.50). The degree of fatty liver showed an independent (OR 1.37 95% CI: 1.03–1.80) and dose‐dependent relationship (moderate‐severe fatty liver: OR 1.55 95% CI: 1.07–2.23, P for trend = 0.014) with large GBPs (≥ 5 mm). Conclusion Fatty liver, an ectopic regional fat deposit, was found to be closely associated with GBPs independent of known metabolic risk factors, insulin resistance, and CT‐measured VAT, confirming a relevant clinical relationship between the two diseases.
Author Lim, Seon Hee
Yim, Jeong Yun
Kim, Donghee
Kim, Joo Sung
Song, Ji Hyun
Kang, Jin Hwa
Cho, Sang-Heon
Chung, Su Jin
Yang, Sun Young
Author_xml – sequence: 1
  givenname: Seon Hee
  surname: Lim
  fullname: Lim, Seon Hee
  organization: Department of Internal Medicine, Healthcare Research Institute, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, South Korea
– sequence: 2
  givenname: Donghee
  surname: Kim
  fullname: Kim, Donghee
  email: messmd@chol.com
  organization: Department of Internal Medicine, Healthcare Research Institute, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, South Korea
– sequence: 3
  givenname: Jin Hwa
  surname: Kang
  fullname: Kang, Jin Hwa
  organization: Department of Radiology, Healthcare Research Institute, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, South Korea
– sequence: 4
  givenname: Ji Hyun
  surname: Song
  fullname: Song, Ji Hyun
  organization: Department of Internal Medicine, Healthcare Research Institute, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, South Korea
– sequence: 5
  givenname: Sun Young
  surname: Yang
  fullname: Yang, Sun Young
  organization: Department of Internal Medicine, Healthcare Research Institute, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, South Korea
– sequence: 6
  givenname: Jeong Yun
  surname: Yim
  fullname: Yim, Jeong Yun
  organization: Department of Internal Medicine, Healthcare Research Institute, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, South Korea
– sequence: 7
  givenname: Su Jin
  surname: Chung
  fullname: Chung, Su Jin
  organization: Department of Internal Medicine, Healthcare Research Institute, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, South Korea
– sequence: 8
  givenname: Joo Sung
  surname: Kim
  fullname: Kim, Joo Sung
  organization: Department of Internal Medicine, Healthcare Research Institute, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, South Korea
– sequence: 9
  givenname: Sang-Heon
  surname: Cho
  fullname: Cho, Sang-Heon
  organization: Department of Internal Medicine, Healthcare Research Institute, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, South Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25376159$$D View this record in MEDLINE/PubMed
BookMark eNp9kM1u1DAURi1URKcDC14AeQkSaf2XOGFXRTBD1RaEQF1aN47T8eCJU9uh5O1JO20XSHAl60rW-a70nSN00PveIPSakmM6z8n2enNMWSnoM7SgQpCMSlEcoAUpaZ5VnFaH6CjGLSFEEJm_QIcs57KgebVA3doMkKzGHaT3uPcJ_7JRmwBu_2Mjhhi9tpBMi29t2uBrcK5x0LYm4MG7aYgf8CmOaWwn7DvMCsHxxoBLmwnHsdkaneJL9LwDF82rh71EPz59_F6vs_Mvq8_16XmmecFp1pjOyFYDkSUjFeMlmLkKlRIK0oiqLYAIXYLkbG4AICUzomENa0EKzTvGl-jt_u4Q_M1oYlK7uzrOQW_8GBUtCiEEJ_NbojcP6NjsTKuGYHcQJvXoZgbe7QEdfIzBdE8IJerOu5q9q3vvM3vyF6ttmr36PgWw7n-JW-vM9O_T6my1fkxk-4SNyfx-SkD4qQrJZa6uLleqruqaXH39pi74H0NboT8
CitedBy_id crossref_primary_10_1097_MD_0000000000029643
crossref_primary_10_17116_terarkh2017891128_133
crossref_primary_10_3748_wjg_v26_i44_6979
crossref_primary_10_1016_j_hbpd_2024_01_006
crossref_primary_10_1097_MEG_0000000000001814
crossref_primary_10_21518_2079_701X_2022_16_14_70_78
crossref_primary_10_1016_j_asjsur_2019_03_015
crossref_primary_10_1097_CM9_0000000000003019
crossref_primary_10_22141_2224_0721_17_3_2021_232650
crossref_primary_10_1186_s12944_021_01452_6
crossref_primary_10_2147_IJGM_S399812
crossref_primary_10_1038_s41598_024_73429_1
crossref_primary_10_3389_fmed_2022_865458
crossref_primary_10_1186_s12957_025_03671_y
crossref_primary_10_1186_s12876_018_0882_z
Cites_doi 10.1111/j.1440-1746.2007.05071.x
10.1056/NEJMoa021423
10.1038/ajg.2009.238
10.1016/j.dld.2010.01.021
10.3346/jkms.2013.28.6.876
10.1111/j.1365-2036.2007.03246.x
10.1002/hep.510310206
10.1016/0037-198X(91)90015-G
10.1161/CIRCULATIONAHA.106.675355
10.7863/jum.1998.17.4.207
10.1097/00004836-199609000-00021
10.1136/gut.2007.147090
10.3748/wjg.v19.i27.4393
10.2337/diabetes.52.10.2490
10.1001/archinte.165.7.777
10.1080/00365521.1990.12067104
10.1073/pnas.0904944106
10.2337/diabetes.50.8.1844
10.2337/dc08-1359
10.1007/BF00280883
10.5009/gnl.2007.1.2.138
10.2337/diacare.27.10.2444
10.1111/j.1365-2036.2011.04724.x
10.1016/S0140-6736(08)60269-X
10.1038/sj.bjc.6604616
10.2337/diabetes.49.5.749
10.1186/1471-230X-8-41
10.1053/gast.2002.36572
10.1097/00000658-200111000-00011
10.1053/jhep.2003.50161
10.1007/s00535-006-1790-5
10.3350/cmh.2013.19.4.325
10.1053/gast.2002.35354
10.1111/j.1572-0241.1999.875_d.x
10.2337/diacare.28.7.1810
10.1001/archinte.163.4.427
ContentType Journal Article
Copyright 2014 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd
2014 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.
Copyright_xml – notice: 2014 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd
– notice: 2014 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.
DBID BSCLL
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1111/jgh.12841
DatabaseName Istex
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1440-1746
EndPage 774
ExternalDocumentID 25376159
10_1111_jgh_12841
JGH12841
ark_67375_WNG_C9CC0WPR_M
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Seoul National University Hospital Research Fund
  funderid: 042009100 (2009–4718)
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
1OB
1OC
29K
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AHEFC
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
D-I
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DTERQ
DU5
EBS
EJD
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
KMS
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
TEORI
UB1
W8V
W99
WBKPD
WH7
WHWMO
WIH
WIJ
WIK
WOHZO
WOQ
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
YFH
ZZTAW
~IA
~WT
AAHQN
AAIPD
AAMNL
AANHP
AAYCA
ACRPL
ACYXJ
ADNMO
AFWVQ
ALVPJ
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c3631-befe7dca078209238ae174177a60b49d6a04c8a732253aa772e4b2b2da74c3f23
IEDL.DBID DR2
ISSN 0815-9319
1440-1746
IngestDate Sun Aug 24 04:01:56 EDT 2025
Mon Jul 21 05:57:34 EDT 2025
Thu Apr 24 22:57:12 EDT 2025
Tue Jul 01 01:45:08 EDT 2025
Wed Jan 22 17:02:14 EST 2025
Wed Oct 30 09:53:16 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords fatty liver
gallbladder polyps
insulin resistance
visceral fat
Language English
License 2014 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3631-befe7dca078209238ae174177a60b49d6a04c8a732253aa772e4b2b2da74c3f23
Notes ArticleID:JGH12841
Seoul National University Hospital Research Fund - No. 042009100 (2009-4718)
Table S1 Multivariate analysis of association between GBP and risk factors in terms of insulin level.
istex:0ACD354B7ACAAA78D216D67920E3E662AF2B3AE0
ark:/67375/WNG-C9CC0WPR-M
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 25376159
PQID 1664443044
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_1664443044
pubmed_primary_25376159
crossref_primary_10_1111_jgh_12841
crossref_citationtrail_10_1111_jgh_12841
wiley_primary_10_1111_jgh_12841_JGH12841
istex_primary_ark_67375_WNG_C9CC0WPR_M
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2015-04
April 2015
2015-04-00
2015-Apr
20150401
PublicationDateYYYYMMDD 2015-04-01
PublicationDate_xml – month: 04
  year: 2015
  text: 2015-04
PublicationDecade 2010
PublicationPlace Australia
PublicationPlace_xml – name: Australia
PublicationTitle Journal of gastroenterology and hepatology
PublicationTitleAlternate J Gastroenterol Hepatol
PublicationYear 2015
Publisher Blackwell Publishing Ltd
Publisher_xml – name: Blackwell Publishing Ltd
References Kratzer W, Haenle MM, Voegtle A et al. Ultrasonographically detected gallbladder polyps: a reason for concern? A seven-year follow-up study. BMC Gastroenterol. 2008; 8: 41-48.
Collett JA, Allan RB, Chisholm RJ, Wilson IR, Burt MJ, Chapman BA. Gallbladder polyps: prospective study. J. Ultrasound Med. 1998; 17: 207-211.
Angulo P. GI epidemiology: nonalcoholic fatty liver disease. Aliment. Pharmacol. Ther. 2007; 25: 883-889.
Mao YS, Mai YF, Li FJ et al. Prevalence and risk factors of gallbladder polypoid lesions in Chinese petrochemical employees. World J. Gastroenterol. 2013; 19: 4393-4399.
Lichtenstein J. The gallbladder: what if it's not stones? Semin. Roentgenol. 1991; 26: 209-215.
Hayashi Y, Liu JH, Moriguchi H et al. Prevalence of polypoid lesions of the gallbladder in urban and rural areas of Japan: comparison between 1988 and 1993. J. Clin. Gastroenterol. 1996; 23: 158-159.
Jorgensen T, Jensen KH. Polyps in the gallbladder: a prevalence study. Scand. J. Gastroenterol. 1990; 25: 281-286.
Kim SY, Lee HS, Lee YS et al. Prevalence and risk factors of gallbladder polyp in adults living in Daegu and Gyeongbuk provinces. Korean J. Gastroenterol. 2006; 48: 344-350.
Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 2003; 348: 1625-1638.
Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 1705-1725.
Lim SH, Kim DH, Park MJ et al. Is metabolic syndrome one of the risk factors for gallbladder polyps found by ultrasonography during health screening? Gut Liver 2007; 1: 138-144.
Park Y, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome. Prevalence and associated risk factor findings in the US population from the third national health and nutrition examination survey, 1988-1994. Arch. Intern. Med. 2003; 163: 427-436.
Segawa K, Arisawa T, Niwa Y et al. Prevalence of gallbladder polyps among apparently healthy Japanese: ultrasonographic study. Am. J. Gastroenterol. 1992; 87: 630-633.
Fox CS, Massaro JM, Hoffmann U et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007; 116: 39-48.
Lin WR, Lin DY, Tai DI et al. Prevalence of and risk factors for gallbladder polyps detected by ultrasonography among healthy Chinese: analysis of 34 669 cases. J. Gastroenterol. Hepatol. 2008; 23: 965-969.
Chung SJ, Kim D, Park MJ et al. Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case-control study of 7078 Koreans undergoing health check-ups. Gut 2008; 57: 1360-1365.
Wagenknecht LE, Langefeld CD, Scherzinger AL et al. Insulin sensitivity, insulin secretion, and abdominal fat: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study. Diabetes 2003; 52: 2490-2496.
Goodpaster BH, Krishnaswami S, Harris TB et al. Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch. Intern. Med. 2005; 165: 777-783.
Choi SY, Kim D, Kim HJ et al. The relation between non-alcoholic fatty liver disease and the risk of coronary heart disease in Koreans. Am. J. Gastroenterol. 2009; 104: 1953-1960.
Eguchi Y, Eguchi T, Mizuta T et al. Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease. J. Gastroenterol. 2006; 41: 462-469.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371: 569-578.
Okamoto M, Okamoto H, Kitahara F et al. Ultrasonographic evidence of association of polyps and stones with gallbladder cancer. Am. J. Gastroenterol. 1999; 94: 446-450.
The Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines: management of nonalcoholic fatty liver disease. Clin. Mol. Hepatol. 2013; 19: 325-348.
World Health Organization. Report of a WHO Consultation on Obesity: Prevention and Managing, the Global Epidemic. Geneva: World Health Organization, 2000. Cited December 2 2012. Available from URL: http://whqlibdoc.who.int/trs/WHO_TRS_894.pdf
Saadeh S, Younossi ZM, Remer EM et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 745-750.
Lim S, Park KS, Lee HK, Cho SI. Changes in the characteristics of metabolic syndrome in Korea over the period 1998-2001 as determined by Korean national health and nutrition examination surveys. Diabetes Care 2005; 28: 1810-1812.
Marchesini G, Brizi M, Bianchi G et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001; 50: 1844-1850.
Hsing AW, Sakoda LC, Rashid A et al. Body size and the risk of biliary tract cancer: a population-based study in China. Br. J. Cancer 2008; 99: 811-815.
Shim SG, Lee KT, Lee JK et al. Prevalence and risk factors of gallbladder polyps in health screening subjects. Korean J. Med. 1999; 57: 1014-1020.
Marchesini G, Bugianesi E, Forlani G et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003; 37: 917-923.
Vernon G, Baranova A, Younossi ZM. The epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment. Pharmacol. Ther. 2011; 34: 274-284.
Ryysy L, Hakkinen AM, Goto T et al. Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes 2000; 49: 749-758.
Loria P, Adinolfi LE, Bellentani S et al. Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. Dig. Liver Dis. 2010; 42: 272-282.
Park EJ, Lee HS, Lee SH et al. Association between metabolic syndrome and gallbladder polyps in healthy Korean adults. J. Korean Med. Sci. 2013; 28: 876-880.
Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 2004; 27: 2444-2449.
Chen CY, Lu CL, Chang FY, Lee SD. Risk factors for gallbladder polyps in the Chinese population. Am. J. Gastroenterol. 1997; 92: 2066-2068.
Fabbrini E, Magkos F, Mohammed BS et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc. Natl. Acad. Sci. U S A 2009; 106: 15430-15435.
Ruhl CE, Everhart JE. Association of diabetes, serum insulin, and C-peptide with gallbladder disease. Hepatology 2000; 31: 299-303.
Pou KM, Massaro JM, Hoffmann U et al. Patterns of abdominal fat distribution: the Framingham Heart Study. Diabetes Care 2009; 32: 481-485.
Csendes A, Burgos AM, Csendes P, Smok G, Rojas J. Late follow-up of polypoid lesions of the gallbladder smaller than 10 mm. Ann. Surg. 2001; 234: 657-660.
1985; 28
2001; 50
2013; 28
2000; 49
2004; 27
2003; 37
2008; 8
2008; 57
2008; 99
2011; 34
2005; 28
2003; 52
2013; 19
2001; 234
1998; 17
2010; 42
2006; 41
2003; 348
2007; 116
2009; 32
1990; 25
1997; 92
1991; 26
2005; 165
2000
2006; 48
2002; 123
2000; 31
1999; 57
2008; 23
1999; 94
1992; 87
2007; 1
2008; 371
2009; 104
2007; 25
1996; 23
2009; 106
2003; 163
e_1_2_6_32_1
e_1_2_6_10_1
e_1_2_6_31_1
e_1_2_6_30_1
e_1_2_6_19_1
e_1_2_6_13_1
e_1_2_6_36_1
e_1_2_6_14_1
e_1_2_6_35_1
e_1_2_6_11_1
e_1_2_6_34_1
e_1_2_6_12_1
Kim SY (e_1_2_6_17_1) 2006; 48
e_1_2_6_33_1
e_1_2_6_18_1
e_1_2_6_39_1
e_1_2_6_15_1
e_1_2_6_38_1
e_1_2_6_37_1
Segawa K (e_1_2_6_5_1) 1992; 87
Shim SG (e_1_2_6_16_1) 1999; 57
e_1_2_6_42_1
World Health Organization (e_1_2_6_22_1) 2000
e_1_2_6_43_1
e_1_2_6_21_1
e_1_2_6_20_1
e_1_2_6_41_1
e_1_2_6_40_1
Chen CY (e_1_2_6_6_1) 1997; 92
e_1_2_6_9_1
e_1_2_6_8_1
e_1_2_6_4_1
e_1_2_6_7_1
e_1_2_6_25_1
e_1_2_6_24_1
e_1_2_6_3_1
e_1_2_6_23_1
e_1_2_6_2_1
e_1_2_6_29_1
e_1_2_6_28_1
e_1_2_6_27_1
e_1_2_6_26_1
References_xml – reference: Shim SG, Lee KT, Lee JK et al. Prevalence and risk factors of gallbladder polyps in health screening subjects. Korean J. Med. 1999; 57: 1014-1020.
– reference: Lin WR, Lin DY, Tai DI et al. Prevalence of and risk factors for gallbladder polyps detected by ultrasonography among healthy Chinese: analysis of 34 669 cases. J. Gastroenterol. Hepatol. 2008; 23: 965-969.
– reference: Wagenknecht LE, Langefeld CD, Scherzinger AL et al. Insulin sensitivity, insulin secretion, and abdominal fat: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study. Diabetes 2003; 52: 2490-2496.
– reference: Chen CY, Lu CL, Chang FY, Lee SD. Risk factors for gallbladder polyps in the Chinese population. Am. J. Gastroenterol. 1997; 92: 2066-2068.
– reference: Kim SY, Lee HS, Lee YS et al. Prevalence and risk factors of gallbladder polyp in adults living in Daegu and Gyeongbuk provinces. Korean J. Gastroenterol. 2006; 48: 344-350.
– reference: Ruhl CE, Everhart JE. Association of diabetes, serum insulin, and C-peptide with gallbladder disease. Hepatology 2000; 31: 299-303.
– reference: Csendes A, Burgos AM, Csendes P, Smok G, Rojas J. Late follow-up of polypoid lesions of the gallbladder smaller than 10 mm. Ann. Surg. 2001; 234: 657-660.
– reference: Mao YS, Mai YF, Li FJ et al. Prevalence and risk factors of gallbladder polypoid lesions in Chinese petrochemical employees. World J. Gastroenterol. 2013; 19: 4393-4399.
– reference: Loria P, Adinolfi LE, Bellentani S et al. Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. Dig. Liver Dis. 2010; 42: 272-282.
– reference: Pou KM, Massaro JM, Hoffmann U et al. Patterns of abdominal fat distribution: the Framingham Heart Study. Diabetes Care 2009; 32: 481-485.
– reference: Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 2004; 27: 2444-2449.
– reference: Collett JA, Allan RB, Chisholm RJ, Wilson IR, Burt MJ, Chapman BA. Gallbladder polyps: prospective study. J. Ultrasound Med. 1998; 17: 207-211.
– reference: Eguchi Y, Eguchi T, Mizuta T et al. Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease. J. Gastroenterol. 2006; 41: 462-469.
– reference: Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 1705-1725.
– reference: Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 2003; 348: 1625-1638.
– reference: Jorgensen T, Jensen KH. Polyps in the gallbladder: a prevalence study. Scand. J. Gastroenterol. 1990; 25: 281-286.
– reference: Marchesini G, Brizi M, Bianchi G et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001; 50: 1844-1850.
– reference: Fabbrini E, Magkos F, Mohammed BS et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc. Natl. Acad. Sci. U S A 2009; 106: 15430-15435.
– reference: Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371: 569-578.
– reference: Park Y, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome. Prevalence and associated risk factor findings in the US population from the third national health and nutrition examination survey, 1988-1994. Arch. Intern. Med. 2003; 163: 427-436.
– reference: Saadeh S, Younossi ZM, Remer EM et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 745-750.
– reference: Park EJ, Lee HS, Lee SH et al. Association between metabolic syndrome and gallbladder polyps in healthy Korean adults. J. Korean Med. Sci. 2013; 28: 876-880.
– reference: Fox CS, Massaro JM, Hoffmann U et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007; 116: 39-48.
– reference: World Health Organization. Report of a WHO Consultation on Obesity: Prevention and Managing, the Global Epidemic. Geneva: World Health Organization, 2000. Cited December 2 2012. Available from URL: http://whqlibdoc.who.int/trs/WHO_TRS_894.pdf
– reference: Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
– reference: The Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines: management of nonalcoholic fatty liver disease. Clin. Mol. Hepatol. 2013; 19: 325-348.
– reference: Lichtenstein J. The gallbladder: what if it's not stones? Semin. Roentgenol. 1991; 26: 209-215.
– reference: Segawa K, Arisawa T, Niwa Y et al. Prevalence of gallbladder polyps among apparently healthy Japanese: ultrasonographic study. Am. J. Gastroenterol. 1992; 87: 630-633.
– reference: Ryysy L, Hakkinen AM, Goto T et al. Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes 2000; 49: 749-758.
– reference: Kratzer W, Haenle MM, Voegtle A et al. Ultrasonographically detected gallbladder polyps: a reason for concern? A seven-year follow-up study. BMC Gastroenterol. 2008; 8: 41-48.
– reference: Hayashi Y, Liu JH, Moriguchi H et al. Prevalence of polypoid lesions of the gallbladder in urban and rural areas of Japan: comparison between 1988 and 1993. J. Clin. Gastroenterol. 1996; 23: 158-159.
– reference: Chung SJ, Kim D, Park MJ et al. Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case-control study of 7078 Koreans undergoing health check-ups. Gut 2008; 57: 1360-1365.
– reference: Lim S, Park KS, Lee HK, Cho SI. Changes in the characteristics of metabolic syndrome in Korea over the period 1998-2001 as determined by Korean national health and nutrition examination surveys. Diabetes Care 2005; 28: 1810-1812.
– reference: Hsing AW, Sakoda LC, Rashid A et al. Body size and the risk of biliary tract cancer: a population-based study in China. Br. J. Cancer 2008; 99: 811-815.
– reference: Okamoto M, Okamoto H, Kitahara F et al. Ultrasonographic evidence of association of polyps and stones with gallbladder cancer. Am. J. Gastroenterol. 1999; 94: 446-450.
– reference: Lim SH, Kim DH, Park MJ et al. Is metabolic syndrome one of the risk factors for gallbladder polyps found by ultrasonography during health screening? Gut Liver 2007; 1: 138-144.
– reference: Vernon G, Baranova A, Younossi ZM. The epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment. Pharmacol. Ther. 2011; 34: 274-284.
– reference: Angulo P. GI epidemiology: nonalcoholic fatty liver disease. Aliment. Pharmacol. Ther. 2007; 25: 883-889.
– reference: Goodpaster BH, Krishnaswami S, Harris TB et al. Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch. Intern. Med. 2005; 165: 777-783.
– reference: Choi SY, Kim D, Kim HJ et al. The relation between non-alcoholic fatty liver disease and the risk of coronary heart disease in Koreans. Am. J. Gastroenterol. 2009; 104: 1953-1960.
– reference: Marchesini G, Bugianesi E, Forlani G et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003; 37: 917-923.
– volume: 28
  start-page: 412
  year: 1985
  end-page: 419
  article-title: Homeostasis model assessment: insulin resistance and beta‐cell function from fasting plasma glucose and insulin concentrations in man
  publication-title: Diabetologia
– volume: 57
  start-page: 1360
  year: 2008
  end-page: 1365
  article-title: Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross‐sectional case‐control study of 7078 Koreans undergoing health check‐ups
  publication-title: Gut
– volume: 348
  start-page: 1625
  year: 2003
  end-page: 1638
  article-title: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults
  publication-title: N. Engl. J. Med.
– volume: 371
  start-page: 569
  year: 2008
  end-page: 578
  article-title: Body‐mass index and incidence of cancer: a systematic review and meta‐analysis of prospective observational studies
  publication-title: Lancet
– volume: 57
  start-page: 1014
  year: 1999
  end-page: 1020
  article-title: Prevalence and risk factors of gallbladder polyps in health screening subjects
  publication-title: Korean J. Med.
– volume: 8
  start-page: 41
  year: 2008
  end-page: 48
  article-title: Ultrasonographically detected gallbladder polyps: a reason for concern? A seven‐year follow‐up study
  publication-title: BMC Gastroenterol.
– volume: 50
  start-page: 1844
  year: 2001
  end-page: 1850
  article-title: Nonalcoholic fatty liver disease: a feature of the metabolic syndrome
  publication-title: Diabetes
– volume: 19
  start-page: 4393
  year: 2013
  end-page: 4399
  article-title: Prevalence and risk factors of gallbladder polypoid lesions in Chinese petrochemical employees
  publication-title: World J. Gastroenterol.
– volume: 87
  start-page: 630
  year: 1992
  end-page: 633
  article-title: Prevalence of gallbladder polyps among apparently healthy Japanese: ultrasonographic study
  publication-title: Am. J. Gastroenterol.
– volume: 27
  start-page: 2444
  year: 2004
  end-page: 2449
  article-title: Increasing prevalence of the metabolic syndrome among U.S. adults
  publication-title: Diabetes Care
– volume: 1
  start-page: 138
  year: 2007
  end-page: 144
  article-title: Is metabolic syndrome one of the risk factors for gallbladder polyps found by ultrasonography during health screening?
  publication-title: Gut Liver
– volume: 234
  start-page: 657
  year: 2001
  end-page: 660
  article-title: Late follow‐up of polypoid lesions of the gallbladder smaller than 10 mm
  publication-title: Ann. Surg.
– volume: 104
  start-page: 1953
  year: 2009
  end-page: 1960
  article-title: The relation between non‐alcoholic fatty liver disease and the risk of coronary heart disease in Koreans
  publication-title: Am. J. Gastroenterol.
– year: 2000
– volume: 17
  start-page: 207
  year: 1998
  end-page: 211
  article-title: Gallbladder polyps: prospective study
  publication-title: J. Ultrasound Med.
– volume: 41
  start-page: 462
  year: 2006
  end-page: 469
  article-title: Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease
  publication-title: J. Gastroenterol.
– volume: 48
  start-page: 344
  year: 2006
  end-page: 350
  article-title: Prevalence and risk factors of gallbladder polyp in adults living in Daegu and Gyeongbuk provinces
  publication-title: Korean J. Gastroenterol.
– volume: 25
  start-page: 883
  year: 2007
  end-page: 889
  article-title: GI epidemiology: nonalcoholic fatty liver disease
  publication-title: Aliment. Pharmacol. Ther.
– volume: 116
  start-page: 39
  year: 2007
  end-page: 48
  article-title: Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study
  publication-title: Circulation
– volume: 49
  start-page: 749
  year: 2000
  end-page: 758
  article-title: Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients
  publication-title: Diabetes
– volume: 123
  start-page: 1705
  year: 2002
  end-page: 1725
  article-title: AGA technical review on nonalcoholic fatty liver disease
  publication-title: Gastroenterology
– volume: 32
  start-page: 481
  year: 2009
  end-page: 485
  article-title: Patterns of abdominal fat distribution: the Framingham Heart Study
  publication-title: Diabetes Care
– volume: 92
  start-page: 2066
  year: 1997
  end-page: 2068
  article-title: Risk factors for gallbladder polyps in the Chinese population
  publication-title: Am. J. Gastroenterol.
– volume: 99
  start-page: 811
  year: 2008
  end-page: 815
  article-title: Body size and the risk of biliary tract cancer: a population‐based study in China
  publication-title: Br. J. Cancer
– volume: 42
  start-page: 272
  year: 2010
  end-page: 282
  article-title: Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee
  publication-title: Dig. Liver Dis.
– volume: 37
  start-page: 917
  year: 2003
  end-page: 923
  article-title: Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome
  publication-title: Hepatology
– volume: 28
  start-page: 1810
  year: 2005
  end-page: 1812
  article-title: Changes in the characteristics of metabolic syndrome in Korea over the period 1998–2001 as determined by Korean national health and nutrition examination surveys
  publication-title: Diabetes Care
– volume: 25
  start-page: 281
  year: 1990
  end-page: 286
  article-title: Polyps in the gallbladder: a prevalence study
  publication-title: Scand. J. Gastroenterol.
– volume: 28
  start-page: 876
  year: 2013
  end-page: 880
  article-title: Association between metabolic syndrome and gallbladder polyps in healthy Korean adults
  publication-title: J. Korean Med. Sci.
– volume: 31
  start-page: 299
  year: 2000
  end-page: 303
  article-title: Association of diabetes, serum insulin, and C‐peptide with gallbladder disease
  publication-title: Hepatology
– volume: 23
  start-page: 965
  year: 2008
  end-page: 969
  article-title: Prevalence of and risk factors for gallbladder polyps detected by ultrasonography among healthy Chinese: analysis of 34 669 cases
  publication-title: J. Gastroenterol. Hepatol.
– volume: 163
  start-page: 427
  year: 2003
  end-page: 436
  article-title: The metabolic syndrome. Prevalence and associated risk factor findings in the US population from the third national health and nutrition examination survey, 1988–1994
  publication-title: Arch. Intern. Med.
– volume: 94
  start-page: 446
  year: 1999
  end-page: 450
  article-title: Ultrasonographic evidence of association of polyps and stones with gallbladder cancer
  publication-title: Am. J. Gastroenterol.
– volume: 34
  start-page: 274
  year: 2011
  end-page: 284
  article-title: The epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults
  publication-title: Aliment. Pharmacol. Ther.
– volume: 52
  start-page: 2490
  year: 2003
  end-page: 2496
  article-title: Insulin sensitivity, insulin secretion, and abdominal fat: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study
  publication-title: Diabetes
– volume: 26
  start-page: 209
  year: 1991
  end-page: 215
  article-title: The gallbladder: what if it's not stones?
  publication-title: Semin. Roentgenol.
– volume: 165
  start-page: 777
  year: 2005
  end-page: 783
  article-title: Obesity, regional body fat distribution, and the metabolic syndrome in older men and women
  publication-title: Arch. Intern. Med.
– volume: 123
  start-page: 745
  year: 2002
  end-page: 750
  article-title: The utility of radiological imaging in nonalcoholic fatty liver disease
  publication-title: Gastroenterology
– volume: 23
  start-page: 158
  year: 1996
  end-page: 159
  article-title: Prevalence of polypoid lesions of the gallbladder in urban and rural areas of Japan: comparison between 1988 and 1993
  publication-title: J. Clin. Gastroenterol.
– volume: 19
  start-page: 325
  year: 2013
  end-page: 348
  article-title: KASL clinical practice guidelines: management of nonalcoholic fatty liver disease
  publication-title: Clin. Mol. Hepatol.
– volume: 106
  start-page: 15430
  year: 2009
  end-page: 15435
  article-title: Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity
  publication-title: Proc. Natl. Acad. Sci. U S A
– volume: 92
  start-page: 2066
  year: 1997
  ident: e_1_2_6_6_1
  article-title: Risk factors for gallbladder polyps in the Chinese population
  publication-title: Am. J. Gastroenterol.
– ident: e_1_2_6_9_1
  doi: 10.1111/j.1440-1746.2007.05071.x
– volume: 48
  start-page: 344
  year: 2006
  ident: e_1_2_6_17_1
  article-title: Prevalence and risk factors of gallbladder polyp in adults living in Daegu and Gyeongbuk provinces
  publication-title: Korean J. Gastroenterol.
– ident: e_1_2_6_11_1
  doi: 10.1056/NEJMoa021423
– ident: e_1_2_6_25_1
  doi: 10.1038/ajg.2009.238
– ident: e_1_2_6_43_1
  doi: 10.1016/j.dld.2010.01.021
– ident: e_1_2_6_29_1
  doi: 10.3346/jkms.2013.28.6.876
– ident: e_1_2_6_33_1
  doi: 10.1111/j.1365-2036.2007.03246.x
– ident: e_1_2_6_28_1
  doi: 10.1002/hep.510310206
– ident: e_1_2_6_24_1
  doi: 10.1016/0037-198X(91)90015-G
– ident: e_1_2_6_36_1
  doi: 10.1161/CIRCULATIONAHA.106.675355
– ident: e_1_2_6_4_1
  doi: 10.7863/jum.1998.17.4.207
– ident: e_1_2_6_10_1
  doi: 10.1097/00004836-199609000-00021
– volume-title: Report of a WHO Consultation on Obesity: Prevention and Managing, the Global Epidemic
  year: 2000
  ident: e_1_2_6_22_1
– ident: e_1_2_6_27_1
  doi: 10.1136/gut.2007.147090
– ident: e_1_2_6_8_1
  doi: 10.3748/wjg.v19.i27.4393
– ident: e_1_2_6_35_1
  doi: 10.2337/diabetes.52.10.2490
– ident: e_1_2_6_37_1
  doi: 10.1001/archinte.165.7.777
– ident: e_1_2_6_3_1
  doi: 10.1080/00365521.1990.12067104
– ident: e_1_2_6_20_1
  doi: 10.1073/pnas.0904944106
– ident: e_1_2_6_18_1
  doi: 10.2337/diabetes.50.8.1844
– ident: e_1_2_6_38_1
  doi: 10.2337/dc08-1359
– ident: e_1_2_6_23_1
  doi: 10.1007/BF00280883
– ident: e_1_2_6_7_1
  doi: 10.5009/gnl.2007.1.2.138
– ident: e_1_2_6_40_1
  doi: 10.2337/diacare.27.10.2444
– ident: e_1_2_6_31_1
  doi: 10.1111/j.1365-2036.2011.04724.x
– ident: e_1_2_6_13_1
  doi: 10.1016/S0140-6736(08)60269-X
– ident: e_1_2_6_12_1
  doi: 10.1038/sj.bjc.6604616
– ident: e_1_2_6_32_1
  doi: 10.2337/diabetes.49.5.749
– volume: 57
  start-page: 1014
  year: 1999
  ident: e_1_2_6_16_1
  article-title: Prevalence and risk factors of gallbladder polyps in health screening subjects
  publication-title: Korean J. Med.
– ident: e_1_2_6_2_1
  doi: 10.1186/1471-230X-8-41
– ident: e_1_2_6_42_1
  doi: 10.1053/gast.2002.36572
– ident: e_1_2_6_21_1
– ident: e_1_2_6_15_1
  doi: 10.1097/00000658-200111000-00011
– ident: e_1_2_6_30_1
  doi: 10.1053/jhep.2003.50161
– ident: e_1_2_6_34_1
  doi: 10.1007/s00535-006-1790-5
– ident: e_1_2_6_19_1
  doi: 10.3350/cmh.2013.19.4.325
– ident: e_1_2_6_26_1
  doi: 10.1053/gast.2002.35354
– ident: e_1_2_6_14_1
  doi: 10.1111/j.1572-0241.1999.875_d.x
– ident: e_1_2_6_41_1
  doi: 10.2337/diacare.28.7.1810
– volume: 87
  start-page: 630
  year: 1992
  ident: e_1_2_6_5_1
  article-title: Prevalence of gallbladder polyps among apparently healthy Japanese: ultrasonographic study
  publication-title: Am. J. Gastroenterol.
– ident: e_1_2_6_39_1
  doi: 10.1001/archinte.163.4.427
SSID ssj0004075
Score 2.2228377
Snippet Background and Aim Gallbladder polyps (GBPs) appear to be strongly associated with obesity and metabolic disease. To date, the relationship between GBPs and...
Gallbladder polyps (GBPs) appear to be strongly associated with obesity and metabolic disease. To date, the relationship between GBPs and fatty liver has not...
SourceID proquest
pubmed
crossref
wiley
istex
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 767
SubjectTerms Adult
Cross-Sectional Studies
fatty liver
Fatty Liver - complications
Fatty Liver - epidemiology
Fatty Liver - metabolism
Female
Gallbladder Neoplasms - epidemiology
Gallbladder Neoplasms - etiology
gallbladder polyps
Humans
Insulin Resistance
Intra-Abdominal Fat
Lipid Metabolism
Liver - metabolism
Male
Middle Aged
Polyps - epidemiology
Polyps - etiology
Risk Factors
visceral fat
Title Hepatic fat, not visceral fat, is associated with gallbladder polyps: A study of 2643 healthy subjects
URI https://api.istex.fr/ark:/67375/WNG-C9CC0WPR-M/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjgh.12841
https://www.ncbi.nlm.nih.gov/pubmed/25376159
https://www.proquest.com/docview/1664443044
Volume 30
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dS9xAEB_EgvSlttqP86NsSyl9aI4ku_nCJzmqh3AiUtGHwrK72VXxepFLTmr_end2k7SKBelbCJMw2Z2d-c3s7C8An2KT26CdmEAUmgVMRDSQNiwGVJtQKZlHocLTyJPDdHzCDs6SsyXY6c7CeH6IvuCGK8P5a1zgQtZ_L_LziyE6V0x9sFcLAdHxH-oo5kl2bcRLgsLaWcsq5Lp4uifvxaJnOKy_HgOa93GrCzx7q_CjU9n3m1wNF40cqt8P2Bz_85tewosWkJJdb0GvYEnP1mBl0m65r4MZa2y6VsSI5iuZVQ25uawVVrL8ncuaiHaKdUmwrEtwM19O0aXNyXU1vbXqkV3iiGxJZYgFR5T485e3pF5IrATVr-Fk79v30Thof84QKJrSKJDa6KxUwhHuWZSYC22TmyjLRBpKVpSpCJnKRYYOgwphQbxmMpZxKTKmqInpG1ieVTP9DohOkyQVxrpsyWx2GuUqzw3TtNAFDXNTDuBLN01ctczl-AONKe8zmPML7sZtAB970WtP1_GY0Gc3172EmF9hf1uW8NPDfT4qRqPw9OiYTwbwoTMG_hPHdooNyNWi5lFqcSSjIWMDeOutpH9bjAw5FiVatd1c_1sRfrA_dhcbTxfdhOcWsyW-eWgLlpv5Qm9bXNTI924B3AHzGAXW
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB5CAm0vfT-2T7WU0kO92Jb8gl7C0sRNs0sJCcmlCEmWkpDtOqy9pemvr0ay3aakUHozRjZjjWbmm_HoE8Dr2OQ2aCcmEIVmARMRDaQNiwHVJlRK5lGocDfydJaWB2znKDlag_f9XhjPDzEU3NAynL9GA8eC9O9WfnwyRu9qc58NPNHbJVR7v8ijmKfZtTEvCQq70jpeIdfH0z96KRpt4MR-vwpqXkauLvRs3YIvvdC-4-RsvGrlWP34g8_xf7_qNtzsMCnZ9IvoDqzpxV24Nu3-ut8DU2rsu1bEiPYdWdQt-XbaKCxm-TunDRGdlnVFsLJL8H--nKNXW5Lzen5h5SObxHHZktoQi48o8VswL0izklgMau7DwdaH_UkZdOczBIqmNAqkNjqrlHCcexYo5kLb_CbKMpGGkhVVKkKmcpGhz6BCWByvmYxlXImMKWpi-gDWF_VCPwKi0yRJhbFeWzKboEa5ynPDNC10QcPcVCN42-uJq468HM_QmPMhiTk-4W7eRvBqGHruGTuuGvTGKXsYIZZn2OKWJfxwts0nxWQSHn7e49MRvOxXA_-KczvHHuR61fAotVCS0ZCxETz0y2R4W4wkORYoWrGdsv8uCN_ZLt3F438f-gKul_vTXb77cfbpCdywEC7xvURPYb1drvQzC5Na-dxZw09MOwnx
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3ta9QwGA9jg-EXdb7tnJtRRPxgj7ZJ2xQ_jZu3c3rHGI7tgxCSNNnGbtfj2hPnX788SVudTBC_lZKWp3nefnny5FeE3sSG2aSdmEDkmgZURCSQNi0GRJtQKcmiUMFp5PEkHR3Tg9PkdAV9aM_CeH6IruAGnuHiNTj4vDC_O_nZeR-Cq136rNE0ZGDSe0e_uKOoZ9m1KS8JcmtoDa2Qa-NpH72VjNZgXn_chTRvA1eXeYYP0LdWZt9wctlf1rKvfv5B5_ifH_UQ3W8QKd71JrSBVvTsEVofN3vuj5EZaei6VtiI-j2elTX-flEpKGX5OxcVFo2OdYGhrothN19OIaYt8LycXlvx8C52TLa4NNiiI4L9AcxrXC0llIKqJ-h4-PHrYBQ0f2cIFElJFEhtdFYo4Rj3LExkQtvVTZRlIg0lzYtUhFQxkUHEIEJYFK-pjGVciIwqYmLyFK3OypneRFinSZIKY2O2pHZ5GjHFmKGa5DonITNFD71r1cRVQ10Of9CY8m4Jc3bO3bz10Otu6Nzzddw16K3TdTdCLC6hwS1L-Mlknw_ywSA8OTzi4x561RoDv4K5nUIHcrmseJRaIElJSGkPPfNW0r0tBoocCxOt2E7XfxeEH-yP3MXzfx_6Eq0f7g35l0-Tz1vonsVviW8keoFW68VSb1uMVMsd5ws3P-UIqQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hepatic+fat%2C+not+visceral+fat%2C+is+associated+with+gallbladder+polyps%3A+A+study+of+2643+healthy+subjects&rft.jtitle=Journal+of+gastroenterology+and+hepatology&rft.au=Lim%2C+Seon+Hee&rft.au=Kim%2C+Donghee&rft.au=Kang%2C+Jin+Hwa&rft.au=Song%2C+Ji+Hyun&rft.date=2015-04-01&rft.issn=0815-9319&rft.eissn=1440-1746&rft.volume=30&rft.issue=4&rft.spage=767&rft.epage=774&rft_id=info:doi/10.1111%2Fjgh.12841&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_jgh_12841
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0815-9319&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0815-9319&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0815-9319&client=summon